Most cancers, including head and neck squamous cell carcinoma (HNSC) and bladder cancer (BLCA), have increased STEAP3, whereas it was downregulated in some cancers, such as breast cancer (BRCA) (Figure 3G). This evidence concerns the gene STEAP3 and urinary bladder carcinoma.